ExodusPoint Capital Management’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$555K Sell
34,961
-3,067
-8% -$53.6K ﹤0.01% 1163
2025
Q4
$675K Sell
38,028
-3,388
-8% -$59.3K 0.01% 1112
2025
Q3
$767K Buy
41,416
+28,946
+232% +$596K 0.01% 1049
2025
Q2
$268K Sell
12,470
-17,512
-58% -$379K ﹤0.01% 1262
2025
Q1
$738K Buy
+29,982
New +$740K 0.01% 1006
2024
Q2
Sell
-232,293
Closed -$6.77M 1757
2024
Q1
$6.77M Buy
+232,293
New +$6.5M 0.05% 306
2023
Q4
Sell
-10,194
Closed -$326K 1767
2023
Q3
$326K Buy
10,194
+4,634
+83% +$178K ﹤0.01% 1392
2023
Q2
$244K Sell
5,560
-6,859
-55% -$316K ﹤0.01% 1627
2023
Q1
$550K Buy
12,419
+2,826
+29% +$125K ﹤0.01% 1311
2022
Q4
$381K Buy
+9,593
New +$400K 0.01% 1279
2020
Q3
Sell
-23,638
Closed -$1.03M 1994
2020
Q2
$1.03M Buy
+23,638
New +$1.06M 0.03% 725
2019
Q4
Sell
-7,700
Closed -$272K 1710
2019
Q3
$272K Buy
7,700
+500
+7% +$17.3K 0.01% 946
2019
Q2
$281K Buy
+7,200
New +$290K 0.01% 731

Other funds holding KIDS

ExodusPoint Capital Management's KIDS Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its OrthoPediatrics (KIDS) stake by 8.1% in Q1 2026, selling an estimated $53.6K and leaving 34,961 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #1163.

ExodusPoint Capital Management first reported a position in KIDS in Q2 2019 and has held it in 13 quarters since. The position peaked at $6.77M in Q1 2024. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • ExodusPoint Capital Management held 34,961 shares of OrthoPediatrics worth $555K as of Q1 2026.
  • ExodusPoint Capital Management sold 3,067 OrthoPediatrics shares in Q1 2026, an estimated $53.6K.
  • OrthoPediatrics made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1163 holding.
  • ExodusPoint Capital Management first reported a position in OrthoPediatrics in Q2 2019 and has held it in 13 quarters since.
  • ExodusPoint Capital Management's OrthoPediatrics position peaked at $6.77M in Q1 2024.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.